Moneycontrol
SENSEX NIFTY
You are here : Moneycontrol > Mutual Funds > Sector - Pharma & Healthcare > Tata Mutual Fund > Tata India Pharma & HealthCare Fund - Direct Plan (G)

Tata India Pharma & HealthCare Fund - Direct Plan (G)

PLAN: Direct OPTIONS: Growth
8.970 0.05 (0.59%)

NAV as on 21 Jun, 2018

CRISIL MF RANK

Not Ranked

Riskometer

MODERATELY HIGH

MODERATELY HIGH

  • Principal at moderately high risk.
FUND FAMILY : Tata Mutual Fund FUND CLASS : Sector - Pharma & Healthcare
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
ranking by CRISIL

Not Ranked

This scheme is not ranked by CRISIL (for quarter ended Mar 2018) since it does not fulfill certain eligibility criteria of CRISIL

View Top ranked funds in other categories

Benchmark Index:
 
View Historic Graph From     To     

Returns (NAV as on 21 Jun, 2018)

Period Returns (%) Rank #
1 mth 6.9 5
3 mth 3.3 3
6 mth -1.0 3
1 year 1.3 4
2 year -0.7 4
3 year - -
5 year - -

# Moneycontrol Rank within 12 Sector - Pharma & Healthcare Schemes.

Absolute Returns (in %)

Year Qtr 1 Qtr 2 Qtr 3 Qtr 4 Annual
2018 -6.5 - - - -
2017 6.3 -5.4 -6.1 9.2 5.8
2016 -6.2 - 1.3 -10.7 -13.2
2015 - - - - -

View where it stands within its peers

* Returns over 1 year are Annualised

* Calculation Remark - Dividends are reinvested at the rate of return

Performance

Fund returns v/s Category average (Sector - Pharma & Healthcare)

* Returns over 1 year are Annualised
  1 mth (%) 3 mth (%) 6 mth (%) 1 yr (%) 2 yr (%) 3 yr (%) 5yr (%)
Fund Returns 6.9 3.3 -1.0 1.3 -0.7 -- --
Category avg 4.9 2.3 -3.0 2.4 -1.0 -1.1 9.9
Difference of Fund returns and Category returns 2.0 1.0 2.0 -1.1 0.3 -- --
Best of category 8.2 7.5 2.0 13.9 6.4 4.2 16.4
Worst of category 4.9 -3.0 -11.4 -7.0 -6.2 -5.5 10.9
Benchmark returns # 16.4 8.3 0.1 -2.0 -6.8 -7.9 7.0
Difference of Fund returns and Benchmark returns -9.5 -5.0 -1.1 3.3 6.1 -- --
# Benchmark Index: NIFTY PHARMA

Investment Info

Investment Objective

Scheme details

Fund Type Open-Ended
Investment Plan Dividend
Launch date Dec 18, 2015
Benchmark NIFTY PHARMA
Asset Size (Rs cr) 19.96 (Mar-31-2018)
Minimum Investment Rs.5000
Last Dividend N.A. View Dividend History
Bonus N.A.
Fund Manager Sonam Udasi / Rupesh Patel
View performance of schemes managed by the Fund Manager
Notes N.A

Load Details

Entry Load N.A
Exit Load 0.25%
Load Comments Exit load - 0.25% if redeemed/switched out on or before expiry of 3 months from the date of allotment.

Contact Details

Regd. Office Mulla House, 4th Floor, 51 M.G. Road, Flora Fountain, Mumbai , 400001
Tel. No. 022 66315191/92/93
Fax No. 022 66315194
Email service@tataamc.com
Website http://www.tatamutualfund.com

Peer Comparison

Sector - Pharma & Healthcare Crisil Rank Assets (Rs.cr)
3mth (%) 6mth (%) 1yr (%) 3yr (%) 5yr (%)
Reliance Pharma Fund (G) Not Ranked
1,695.82 7.3 1.6 12.9 3.2 15.4
Reliance Pharma Fund - Direct (G) Not Ranked
258.39 7.5 2.0 13.9 4.2 16.4
SBI Healthcare Opportunities (G) Not Ranked
828.41 -3.0 -11.4 -7.0 -5.5 12.9
SBI Healthcare Opportunities - D (G) Not Ranked
218.21 -2.7 -10.8 -5.8 -4.3 14.2
UTI Healthcare Fund (G) Not Ranked
362.92 0.0 -6.2 0.5 -3.1 10.9
* Returns over 1 year are Annualised More »

Portfolio

Top Holdings (May 31, 18)

Equity Sector Value
(Rs cr)
Asset %
Sun Pharma Pharmaceuticals 20.65 15.52
Piramal Enter Pharmaceuticals 12.74 9.58
Ipca Labs Pharmaceuticals 12.72 9.56
Syngene Intl Miscellaneous 10.64 7.99
Dishman Carboge Miscellaneous 8.00 6.02
Apollo Hospital Services 7.44 5.59
Sanofi India Pharmaceuticals 6.25 4.70
Divis Labs Pharmaceuticals 6.24 4.69
Abbott India Pharmaceuticals 6.03 4.53
Cadila Health Pharmaceuticals 5.43 4.08

Full Portfolio

Sector Allocation (May 31, 18)

Sector %

1-Year

HighLow

Pharmaceuticals 72.32 74.72 74.72
Miscellaneous 14.01 14.09 14.09
Services 5.59 4.91 4.91

View All Sectors

Asset Allocation (%)(May 31, 18)

Equity 91.92
Others 0.00
Debt 0.00
Mutual Funds N.A
Money Market 0.00
Cash / Call 8.10

View All

Concentration

Holdings (%)
Top 5 48.67
Top 10 72.26
Sector (%)
Top 3 91.92

News & Videos

News

Messages & Community

Sections
Follow us on
Available On